A pharmaceutical formulation development expert whose professional experience spans 29 years, he specializes in sterile product formulation, injectable products, clinical manufacturing, drug delivery systems, peptide and protein formulations, aseptic processing, formulation development, technology transfer, development pharmaceutics, and regulatory compliance. His expertise also includes sustained-release parenteral technologies, formulation excipients, package selection, criticality analysis, IND/NDA development, CMC coordination, and GMP- and FDA-regulated pharmaceutical research and manufacturing. He has held licensure as a Registered Pharmacist in New York and has 4 years of expert witness experience involving patent litigation.

His professional background includes service as Pharmaceutical Consultant and Principal of a pharmaceutical consulting firm, Research Director and Global Head of Sterile Product Formulation, Research Director of Sterile Product Formulation and Clinical Manufacturing, Director of Clinical Manufacturing, Research Leader, Research Investigator, Associate Research Investigator, Senior Scientist, Scientist, and Clinical Materials Pharmacist for global pharmaceutical manufacturers. In these roles, he led formulation development for injectable, oral, and sterile drug products; directed clinical manufacturing operations; evaluated drug delivery systems and injection devices; managed technology transfer, formulation harmonization, and clinical manufacturing outsourcing; supervised GLP and GMP manufacturing activities; supported CMC development; and oversaw formulation research from preclinical development through marketed products. His consulting experience has also included providing technical guidance to pharmaceutical manufacturers, investment firms, and legal firms on formulation development, primary packaging, preformulation, analytical issues, and pharmaceutical patent litigation.

In addition to his pharmaceutical development and consulting work, he has authored or co-authored peer-reviewed publications, published abstracts, conference presentations, and a U.S. patent involving injectable formulations, peptide and protein drug delivery, lyophilization, cyclodextrin-enabled formulations, biodegradable implants, pharmaceutical stability, and formulation technologies. His qualifications are further supported by a Doctor of Philosophy in Pharmaceutical Sciences, a Master of Science in Pharmaceutical Sciences, a Bachelor of Science in Pharmacy, prior licensure as a Registered Pharmacist in New York, and professional affiliations with the American Association of Pharmaceutical Scientists, the American Pharmacy Association, and the Parenteral Drug Association.